vs
Arcellx, Inc.（ACLX）与Alpha Cognition Inc.（ACOG）财务数据对比。点击上方公司名可切换其他公司
Alpha Cognition Inc.的季度营收约是Arcellx, Inc.的1.7倍（$2.8M vs $1.7M）。Alpha Cognition Inc.净利率更高（-245.5% vs -3513.4%，领先3267.9%）。Alpha Cognition Inc.自由现金流更多（$-7.1M vs $-58.9M）
Arcellx, Inc.是一家处于临床阶段的生物技术企业，专注开发用于治疗血液恶性肿瘤、实体瘤等难治性癌症的CAR-T细胞疗法，其核心管线针对肿瘤领域未被满足的医疗需求，服务全球患者群体。
ACLX vs ACOG — 直观对比
营收规模更大
ACOG
是对方的1.7倍
$1.7M
净利率更高
ACOG
高出3267.9%
-3513.4%
自由现金流更多
ACOG
多$51.9M
$-58.9M
损益表 — Q4 2025 vs Q4 2025
| 指标 | | |
|---|---|---|
| 营收 | $1.7M | $2.8M |
| 净利润 | $-58.1M | $-6.9M |
| 毛利率 | — | — |
| 营业利润率 | -3850.2% | -283.7% |
| 净利率 | -3513.4% | -245.5% |
| 营收同比 | -89.2% | — |
| 净利润同比 | -23.4% | — |
| 每股收益（稀释后） | $-1.01 | $-0.10 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ACLXACOG
| Q4 25 | $1.7M | $2.8M | ||
| Q3 25 | $4.9M | $2.8M | ||
| Q2 25 | $7.6M | $1.7M | ||
| Q1 25 | $8.1M | $2.9M | ||
| Q4 24 | $15.3M | — | ||
| Q3 24 | $26.0M | — | ||
| Q2 24 | $27.4M | — | ||
| Q1 24 | $39.3M | — |
净利润ACLXACOG
| Q4 25 | $-58.1M | $-6.9M | ||
| Q3 25 | $-55.8M | $-1.3M | ||
| Q2 25 | $-52.8M | $-10.5M | ||
| Q1 25 | $-62.3M | $-2.0M | ||
| Q4 24 | $-47.1M | — | ||
| Q3 24 | $-25.9M | — | ||
| Q2 24 | $-27.2M | — | ||
| Q1 24 | $-7.2M | — |
毛利率ACLXACOG
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | 96.7% | ||
| Q1 25 | — | 99.6% | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
营业利润率ACLXACOG
| Q4 25 | -3850.2% | -283.7% | ||
| Q3 25 | -1248.3% | -187.0% | ||
| Q2 25 | -777.4% | -346.1% | ||
| Q1 25 | -847.6% | -125.9% | ||
| Q4 24 | -348.2% | — | ||
| Q3 24 | -129.1% | — | ||
| Q2 24 | -127.8% | — | ||
| Q1 24 | -40.3% | — |
净利率ACLXACOG
| Q4 25 | -3513.4% | -245.5% | ||
| Q3 25 | -1127.1% | -46.4% | ||
| Q2 25 | -698.6% | -632.7% | ||
| Q1 25 | -766.0% | -68.5% | ||
| Q4 24 | -308.4% | — | ||
| Q3 24 | -99.4% | — | ||
| Q2 24 | -99.3% | — | ||
| Q1 24 | -18.3% | — |
每股收益（稀释后）ACLXACOG
| Q4 25 | $-1.01 | $-0.10 | ||
| Q3 25 | $-0.99 | $-0.30 | ||
| Q2 25 | $-0.94 | $-0.65 | ||
| Q1 25 | $-1.13 | $-0.13 | ||
| Q4 24 | $-0.87 | — | ||
| Q3 24 | $-0.48 | — | ||
| Q2 24 | $-0.51 | — | ||
| Q1 24 | $-0.14 | — |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $450.3M | $66.0M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $402.4M | $62.5M |
| 总资产 | $604.0M | $79.7M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资ACLXACOG
| Q4 25 | $450.3M | $66.0M | ||
| Q3 25 | $461.4M | $35.4M | ||
| Q2 25 | $453.1M | $39.4M | ||
| Q1 25 | $543.3M | $45.5M | ||
| Q4 24 | $587.4M | — | ||
| Q3 24 | $574.3M | — | ||
| Q2 24 | $516.7M | — | ||
| Q1 24 | $573.9M | — |
股东权益ACLXACOG
| Q4 25 | $402.4M | $62.5M | ||
| Q3 25 | $440.8M | $33.9M | ||
| Q2 25 | $392.2M | $31.9M | ||
| Q1 25 | $416.9M | $40.8M | ||
| Q4 24 | $454.8M | — | ||
| Q3 24 | $483.0M | — | ||
| Q2 24 | $487.2M | — | ||
| Q1 24 | $496.6M | — |
总资产ACLXACOG
| Q4 25 | $604.0M | $79.7M | ||
| Q3 25 | $655.9M | $46.3M | ||
| Q2 25 | $619.1M | $45.1M | ||
| Q1 25 | $648.1M | $48.6M | ||
| Q4 24 | $711.3M | — | ||
| Q3 24 | $764.9M | — | ||
| Q2 24 | $734.3M | — | ||
| Q1 24 | $779.7M | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-58.2M | $-6.9M |
| 自由现金流经营现金流 - 资本支出 | $-58.9M | $-7.1M |
| 自由现金流率自由现金流/营收 | -3563.4% | -252.6% |
| 资本支出强度资本支出/营收 | 46.2% | 5.3% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $-212.6M | $-20.7M |
8季度趋势，按日历期对齐
经营现金流ACLXACOG
| Q4 25 | $-58.2M | $-6.9M | ||
| Q3 25 | $-49.2M | $-5.3M | ||
| Q2 25 | $-39.7M | $-6.1M | ||
| Q1 25 | $-63.1M | $-2.0M | ||
| Q4 24 | $-46.0M | — | ||
| Q3 24 | $30.7M | — | ||
| Q2 24 | $-36.2M | — | ||
| Q1 24 | $-31.9M | — |
自由现金流ACLXACOG
| Q4 25 | $-58.9M | $-7.1M | ||
| Q3 25 | $-49.5M | $-5.4M | ||
| Q2 25 | $-40.2M | $-6.1M | ||
| Q1 25 | $-63.9M | $-2.1M | ||
| Q4 24 | $-47.5M | — | ||
| Q3 24 | $28.4M | — | ||
| Q2 24 | $-39.5M | — | ||
| Q1 24 | $-38.3M | — |
自由现金流率ACLXACOG
| Q4 25 | -3563.4% | -252.6% | ||
| Q3 25 | -1000.3% | -188.8% | ||
| Q2 25 | -532.4% | -370.9% | ||
| Q1 25 | -786.4% | -72.0% | ||
| Q4 24 | -311.3% | — | ||
| Q3 24 | 109.2% | — | ||
| Q2 24 | -144.1% | — | ||
| Q1 24 | -97.7% | — |
资本支出强度ACLXACOG
| Q4 25 | 46.2% | 5.3% | ||
| Q3 25 | 6.0% | 2.6% | ||
| Q2 25 | 6.4% | 0.5% | ||
| Q1 25 | 9.6% | 2.2% | ||
| Q4 24 | 9.8% | — | ||
| Q3 24 | 8.8% | — | ||
| Q2 24 | 11.7% | — | ||
| Q1 24 | 16.4% | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
